- Home
- ZCAR vs CERO Comparison
ZCAR vs CERO Comparison
Compare ZCAR & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCAR
- CERO
- Stock Information
- Founded
- ZCAR 2013
- CERO 2017
- Country
- ZCAR India
- CERO United States
- Employees
- ZCAR N/A
- CERO N/A
- Industry
- ZCAR Blank Checks
- CERO
- Sector
- ZCAR Finance
- CERO
- Exchange
- ZCAR Nasdaq
- CERO Nasdaq
- Market Cap
- ZCAR 8.8M
- CERO 8.4M
- IPO Year
- ZCAR N/A
- CERO N/A
- Fundamental
- Price
- ZCAR $1.09
- CERO $2.04
- Analyst Decision
- ZCAR
- CERO
- Analyst Count
- ZCAR 0
- CERO 0
- Target Price
- ZCAR N/A
- CERO N/A
- AVG Volume (30 Days)
- ZCAR 773.0K
- CERO 1.3M
- Earning Date
- ZCAR 02-14-2025
- CERO 02-20-2025
- Dividend Yield
- ZCAR N/A
- CERO N/A
- EPS Growth
- ZCAR N/A
- CERO N/A
- EPS
- ZCAR 1.91
- CERO N/A
- Revenue
- ZCAR $9,089,489.00
- CERO N/A
- Revenue This Year
- ZCAR N/A
- CERO N/A
- Revenue Next Year
- ZCAR N/A
- CERO N/A
- P/E Ratio
- ZCAR $0.58
- CERO N/A
- Revenue Growth
- ZCAR N/A
- CERO N/A
- 52 Week Low
- ZCAR $1.00
- CERO $1.76
- 52 Week High
- ZCAR $214.00
- CERO $1,238.00
- Technical
- Relative Strength Index (RSI)
- ZCAR 31.81
- CERO 32.64
- Support Level
- ZCAR $1.00
- CERO $1.76
- Resistance Level
- ZCAR $1.95
- CERO $3.18
- Average True Range (ATR)
- ZCAR 0.17
- CERO 0.35
- MACD
- ZCAR 0.03
- CERO 0.28
- Stochastic Oscillator
- ZCAR 8.48
- CERO 4.72
About ZCAR Zoomcar Holdings Inc.
Zoomcar Holdings Inc is India's largest marketplace for cars on rent. Zoomcar is a leading emerging-market-focused peer-to-peer car-sharing marketplace, with approximately 21,000 vehicles registered through its platform. The Company derives its revenue principally from short-term self-drive rentals and vehicle subscriptions. The self-drive rental business generates the majority of revenue. Geographically The company operates in India, Egypt, Indonesia, Vietnam, and the Philippines, Out of which the majority of revenue is derived from India.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.